Irfan A. Khan

Irfan A. Khan

Auto-generated profile, based on publicly available information

Irfan A. Khan

Department of Orthopaedic Surgery LSU Health New Orleans New Orleans Louisiana U.S.A.

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2022 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
AHAmer Haffar
Amer Haffar
IKIrfan A. Khan
Irfan A. Khan
MAMohammad S. Abdelaal
Mohammad S. Abdelaal
SBSamik Banerjee
Samik Banerjee
PSPeter F. Sharkey
Peter F. Sharkey
JLJess H. Lonner
Jess H. Lonner

14 March 2023 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
MAMohammad S. Abdelaal
Mohammad S. Abdelaal
BWBright M. Wiafe
Bright M. Wiafe
IKIrfan A. Khan
Irfan A. Khan
JMJustin A. Magnuson
Justin A. Magnuson
ASArjun Saxena
Arjun Saxena
PSPeter F. Sharkey
Peter F. Sharkey

1 September 2022 in JBJS Reviews
Verified
Journal Article
Closed access
IKIrfan A. Khan
Irfan A. Khan
JMJustin A. Magnuson
Justin A. Magnuson
AAArmin Arshi
Armin Arshi
CKChad A. Krueger
Chad A. Krueger
KFKevin B. Freedman
Kevin B. Freedman
YFYale A. Fillingham
Yale A. Fillingham
Background: Hip hemiarthroplasty (HA) is commonly used to treat femoral neck fractures, but it remains unclear if the surgical approach impacts patient outcomes for this commonly performed procedure. The objective of this systematic review and meta-analysis was to assess early postoperative outcomes in patients undergoing HA for femoral neck fracture with the direct anterior approach (DAA) compared with other approaches. Methods: The Cochrane Central Registry of Controlled Trials, MEDLINE, and Google Scholar databases were searched for randomized controlled trials, prospective nonrandomized trials, and retrospective studies published prior to September 7, 2021, comparing DAA with other approaches (anterolateral approach [ALA], direct lateral approach [DLA], and posterior-based approach [PA]) in HA for femoral neck fractures. This study was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Outcomes included functional outcomes, total complications, prosthetic dislocation, periprosthetic fracture, periprosthetic joint infection (PJI), reoperation, mortality, pain, operative time, and perioperative blood loss. Fixed effect odds ratios, along with their 95% confidence intervals, were used to analyze dichotomous variables. Significance was set at p < 0.05. Meta-analysis was conducted with Review Manager 5.4. Results: In total, 19 studies were included for qualitative analysis and 16 studies were included for quantitative analysis, with a total of 1,604 cases analyzed (723 DAA, 215 ALA, 301 DLA, and 365 PA). Compared with other approaches, the use of the DAA for HA was associated with improved early postoperative functional outcomes, lower early postoperative pain scores, fewer total complications, and fewer prosthetic hip dislocations. The rates of periprosthetic fracture, PJI, and reoperation, pain scores beyond 40 days, operative time, perioperative blood loss, and mortality were not significantly different between surgical approaches. Conclusions: Utilizing the DAA while performing HA for femoral neck fractures is associated with improved functional outcomes, lower early postoperative pain scores, lower incidence of prosthetic hip dislocation, and potentially fewer total complications. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

1 April 2022 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
IKIrfan A. Khan
Irfan A. Khan
AHAmer Haffar
Amer Haffar
JMJustin A. Magnuson
Justin A. Magnuson
COChristian Ong
Christian Ong
MAMatthew S. Austin
Matthew S. Austin
JLJess H. Lonner
Jess H. Lonner

1 March 2023 in JBJS Reviews
Verified
Journal Article
Closed access
IKIrfan A. Khan
Irfan A. Khan
BBBrandon O. Boyd
Brandon O. Boyd
ACAntonia F. Chen
Antonia F. Chen
NCNicolás Cortés-Penfield
Nicolás Cortés-Penfield
TMThomas G. Myers
Thomas G. Myers
YFYale A. Fillingham
Yale A. Fillingham
Introduction: Periprosthetic joint infection (PJI) is a devastating complication after total joint arthroplasty (TJA), with treatment failure occurring in 12% to 28% after 2-stage revision. It is vital to identify diagnostic tools indicative of persistent infection or treatment failure after 2-stage revision for PJI. Methods: The Cochrane Library, PubMed (MEDLINE), and EMBASE were searched for randomized controlled trials and comparative observational studies published before October 3, 2021, which evaluated the utility of serum/plasma biomarkers (erythrocyte sedimentation rate [ESR], C-reactive protein [CRP], interleukin-6 [IL-6], fibrinogen, D-dimer), synovial biomarkers (white blood cell [WBC] count, neutrophil percentage [PMN %], alpha-defensin [AD], leukocyte esterase [LE]), tissue frozen section, tissue culture, synovial fluid culture, or sonicated spacer fluid culture indicative of persistent infection before the second stage of 2-stage revision for PJI or treatment failure after 2-stage revision for PJI. Results: A total of 47 studies including 6,605 diagnostic tests among 3,781 2-stage revisions for PJI were analyzed. Among those cases, 723 (19.1%) experienced persistent infection or treatment failure. Synovial LE (sensitivity 0.25 [0.10-0.47], specificity 0.99 [0.93-1.00], positive likelihood ratio 14.0 [1.45-135.58]) and serum IL-6 (sensitivity 0.52 [0.33-0.70], specificity 0.92 [0.85-0.96], positive likelihood ratio 7.90 [0.86-72.61]) had the highest diagnostic accuracy. However, no biomarker was associated with a clinically useful negative likelihood ratio. In subgroup analysis, synovial PMN %, synovial fluid culture, serum ESR, and serum CRP had limited utility for detecting persistent infection before reimplantation (positive likelihood ratios ranging 2.33-3.74; negative likelihood ratios ranging 0.31-0.9) and no utility for predicting failure after the second stage of 2-stage revision. Conclusions: Synovial WBC count, synovial PMN %, synovial fluid culture, serum ESR, and serum CRP have modest sensitivity and specificity for predicting persistent infection during the second stage of 2-stage revision, suggesting some combination of these diagnostic tests might be useful before reimplantation. No biomarker or culture accurately predicted treatment failure after reimplantation. Level of Evidence: Level III. See Instructions for Authors for a complete description of levels of evidence.

17 October 2022 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
MTMichael T. Torchia
Michael T. Torchia
IKIrfan A. Khan
Irfan A. Khan
DCDavid D. Christensen
David D. Christensen
WMWayne E. Moschetti
Wayne E. Moschetti
YFYale A. Fillingham
Yale A. Fillingham